Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matúš Drexler

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
SLAS Technology|June 1, 2026
MOLD: Modular Layout Designer for Echo Liquid HandlersPavel Kraina, Matúš Drexler
Nucleic Acids Research|June 11, 2024
Aurora: a fluorescent deoxyribozyme for high-throughput screeningMartin Volek, Jaroslav Kurfürst, Matúš Drexler, et al.
European Journal of Medicinal Chemistry|November 30, 2025
Exploring advanced methodologies for NS5 methyltransferase targeted drug discoveryTomáš Otava, Matúš Drexler, Petra Krafčíková, et al.
Nature Methods|September 15, 2025
MS<sup>n</sup>Lib: efficient generation of open multi-stage fragmentation mass spectral librariesCorinna Brungs, Robin Schmid, Steffen Heuckeroth, et al.
RSC Medicinal Chemistry|September 2, 2024
Discovery of highly potent SARS-CoV-2 nsp14 methyltransferase inhibitors based on adenosine 5'-carboxamidesHugo Kocek, Dominika Chalupská, Milan Dejmek, et al.
European Journal of Medicinal Chemistry|October 26, 2024
Rational fragment-based design of compounds targeting the PWWP domain of the HRP familyThibault Vantieghem, Nayyar A Aslam, Evgenii M Osipov, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
SLAS Technology|June 1, 2026
MOLD: Modular Layout Designer for Echo Liquid HandlersPavel Kraina, Matúš Drexler
Nucleic Acids Research|June 11, 2024
Aurora: a fluorescent deoxyribozyme for high-throughput screeningMartin Volek, Jaroslav Kurfürst, Matúš Drexler, et al.
European Journal of Medicinal Chemistry|November 30, 2025
Exploring advanced methodologies for NS5 methyltransferase targeted drug discoveryTomáš Otava, Matúš Drexler, Petra Krafčíková, et al.
Nature Methods|September 15, 2025
MS<sup>n</sup>Lib: efficient generation of open multi-stage fragmentation mass spectral librariesCorinna Brungs, Robin Schmid, Steffen Heuckeroth, et al.
RSC Medicinal Chemistry|September 2, 2024
Discovery of highly potent SARS-CoV-2 nsp14 methyltransferase inhibitors based on adenosine 5'-carboxamidesHugo Kocek, Dominika Chalupská, Milan Dejmek, et al.
European Journal of Medicinal Chemistry|October 26, 2024
Rational fragment-based design of compounds targeting the PWWP domain of the HRP familyThibault Vantieghem, Nayyar A Aslam, Evgenii M Osipov, et al.
Pageof 1